Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Biotech
From R&D to M&A: Big Pharmas showcase ‘measurable impact’ of AI
Big Pharmas are moving beyond AI hype and starting to explain how the technology is being used in practice.
James Waldron
May 7, 2026 9:10am
GSK pens $1B deal for metabolic oligonucleotide from SiranBio
May 6, 2026 8:04am
GSK’s $700M Alector bet blows up with 2nd Alzheimer’s fail
Apr 30, 2026 5:15am
Why the next blockbuster in GSK CEO's sights could be in cancer
Apr 29, 2026 7:16am
GSK walks away from $100M bet on Mersana STING ADC
Apr 29, 2026 6:16am
GSK CEO’s ‘scientific courage’ propels ADC toward ph. 3 tests
Apr 12, 2026 10:10am
